The latest from BioStock
» Saniona comments on approval to initiate epilepsy study
» The most shorted life science stocks in the Nordics
» Abliva leads the fight against mitochondrial diseases
» BioInvent's CMO comments on the presentation at ESMO
» Investing in life science: From Seed to Success 2024
Read the newsletter for v.37 here.
See all presentations and panels from BioStock Investing in Life Science – below.
The latest news
Alzinova announces that the first study participant has successfully completed the entire phase Ib study with ALZ-101. Read more.
Vicore publishes a prospectus regarding a rights issue of approximately SEK 782 million. Read more.
Xspray Pharma announces positive meeting with FDA and announces plans for application for market approval for Dasynoc. Read more.
Egetis files a patent application with the United States Patent and Trademark Office for “Manufacturing Processes” of tiratricol. Read more.
Lipigons development partner Leaderna Therapeutics reports that the last person in a phase I clinical trial with Lipisense has been treated. Read more.
Cereno Scientific announces changes to the composition of the Nomination Committee ahead of the 2025 Annual General Meeting. Read more.
Implantica implements the first national RefluxStop-user meeting with 21 participating surgeons, 1,5 years after the launch in Italy. Read more.
DanCann Pharma announces that the number of reported suspected side effects decreased by 2/3 in 2023. Read more.
NanoEcho receives approval from the Swedish Medical Products Agency for use of the iron oxide-based nanoparticle in a planned clinical study. Read more.
Caroline Leksell Cooke takes over the management of Elekta Neuro Solutions. Read more.
Herantis Pharma announces that structural basis for HER-096 design published in Nature Communications. Read more.
Today the subscription period begins in Invent Medics rights issue. Read more.
Gavi, Vaccine Alliance, signs agreement with Bavarian Nordic to quickly secure 500 doses of Mpox vaccine for Africa. Read more.
Last day for trading with Diagonal Cinemas warrants of series TO 1 are September 24, 2024. Read more.
Medim invites you to a digital company presentation and Q&A on September 24th. Read more.
EXACT Therapeutics presenting at ISTU 2024. Read more.
PharmaLundensis The new share issue was subscribed for approximately SEK 4,03 million. Read more.
Summons
This morning's price development
Index: OMXS30 +1,55% Healthcare + 0,40 %
| Winner | Förlorare |
| PharmaLundensis +33,33% | Gabather -15,21% |
| NanoEcho +31,59% | Level Bio -11,43% |
| Ortivus +14,04% | Asarina Pharma -9,97% |
| BiBBInstruments +13,92% | Pila Pharma -9,89% |
| Quia Pharma +13,85% | Bio Vitos Pharma -6,52% |